Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Shareholders' Equity (Details)

v3.24.2.u1
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
May 07, 2024
Apr. 01, 2024
Aug. 30, 2023
Nov. 28, 2013
Jun. 30, 2024
Shareholders' Equity [Line Items]          
Shares held in abeyance         296,891,100
Expenses for shares issued for services (in Dollars)         $ 112
Shares available for future grant         91,000,000
Share grant         9,000,000
Ordinary per share issued (in Dollars per share) $ 0.0275        
Options exercisable         33,998,875
Date of grant         5 years 7 months 6 days
Leiden University [Member]          
Shareholders' Equity [Line Items]          
Shares held in abeyance         157,200,000
Board of Directors [Member]          
Shareholders' Equity [Line Items]          
Increase number of ordinary shares       85,000,000  
Share grant 9,000,000        
Option exerisable 9,000,000        
Ordinary Shares [Member]          
Shareholders' Equity [Line Items]          
Share-based payments shares issued   15,000,000      
Expenses for shares issued for services (in Dollars)         $ 112
Increase number of ordinary shares     100,000,000    
Option exerisable 41,000,000        
Options exercisable 41,000,000        
Date of grant 4 years